Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs.
about
Molecular advances in the cell biology of SARS-CoV and current disease prevention strategiesRespiratory viruses other than influenza virus: impact and therapeutic advancesSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionStrategies adopted and lessons learnt during the severe acute respiratory syndrome crisis in Singapore.A review of treatment modalities for Middle East Respiratory Syndrome.Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.An interferon-gamma-related cytokine storm in SARS patients.The emergence of the Middle East respiratory syndrome coronavirusSingle-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse modelSevere acute respiratory syndrome (SARS): lessons learnt in Hong KongSynthesis and antiviral properties of spirocyclic [1,2,3]-triazolooxazine nucleosides.Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.Advancements in the battle against severe acute respiratory syndrome.Small molecules targeting severe acute respiratory syndrome human coronavirusNew antiviral drugs, vaccines and classic public health interventions against SARS coronavirus.Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome.Treatment of severe acute respiratory syndrome.Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy.Antiviral therapy for respiratory tract infections.Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.Scalable transcriptional analysis routine--multiplexed quantitative real-time polymerase chain reaction platform for gene expression analysis and molecular diagnostics.Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replicationPost-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management.Structural flexibility of the pentameric SARS coronavirus envelope protein ion channel.A patient with severe respiratory failure caused by novel human coronavirus.Clinical issues and research in respiratory failure from severe acute respiratory syndrome.Combined antiherpetic effect of complex preparation "Viferon-eye drops" and modified nucleosides.Severe acute respiratory syndrome
P2860
Q21245141-3B5E5978-B6CF-4C5B-A8EA-75A20192293EQ24655957-4E14681F-37D1-4868-B15D-3DC837CF4075Q28383088-EF9412F0-858A-493F-A9CE-D43EDB49494AQ30233162-E41B69F3-CF41-49CF-9540-49C17810F347Q30248209-A12FA42E-5D80-4A71-A3DF-6B33288E878EQ30276258-65E73F1B-B1B5-4B37-A802-B119007C1DF9Q30357014-34C69223-6572-4D67-A4A9-9B2A92467E62Q33844674-9CC1E9EB-1BA0-4080-8960-C5CED681687AQ33934034-F2B9F97C-6113-4A71-8D91-6D1AFC64960CQ34478750-03A6D9B1-0366-4445-AA9F-7D7BE23E5323Q34974298-31D8D895-7C3F-47B6-8ABC-6B177DE6548BQ35216846-DB656C71-909F-4C54-BA18-9BB92C9F2AE4Q35739055-4DD4E6D2-676E-45D9-A662-C671A2F3176DQ35841566-9A27E766-56F3-4799-B23D-96950468051CQ35970698-0FF58B71-EAFC-4255-8C53-BBC78C773184Q36058647-71B3DEB3-9EFE-4241-A071-0B42E3983C7EQ36140676-241D2878-9FF4-4EDF-AA12-CC0D90B5B639Q36261771-07835724-5018-44EE-BF8F-F6F5DFA61139Q37283689-D3917897-9B7B-4123-A508-7F321A0743B3Q37298680-8E2119EB-D0F7-43D9-8EAC-904490AF1E31Q37481314-5DA7C376-17AB-4E0E-A08A-460069A119B9Q38411725-4963B261-BF65-4DAE-A6E0-7B6ACB471B5BQ39703230-48980210-FB3F-40BD-B999-6127BECC0422Q41927260-90A28BF2-93E0-4CEA-9ECB-AAA64E613E03Q42018641-31D9728E-5A48-4F52-81BD-DDA578595AA5Q42280353-48150CB1-8FDD-46CA-91E2-700BEB832487Q45174339-454FE05E-62CD-4B9C-B27F-CBDECA4DD1E0Q50573805-B99C3225-200D-47C2-8EC7-82773491A2C5Q56775278-C6A97C74-EBC0-44D9-96EC-838EE019361B
P2860
Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inhibition of SARS coronavirus ...... ally approved antiviral drugs.
@ast
Inhibition of SARS coronavirus ...... ally approved antiviral drugs.
@en
type
label
Inhibition of SARS coronavirus ...... ally approved antiviral drugs.
@ast
Inhibition of SARS coronavirus ...... ally approved antiviral drugs.
@en
prefLabel
Inhibition of SARS coronavirus ...... ally approved antiviral drugs.
@ast
Inhibition of SARS coronavirus ...... ally approved antiviral drugs.
@en
P2093
P2860
P356
P1476
Inhibition of SARS coronavirus ...... ally approved antiviral drugs.
@en
P2093
Ai Ee Ling
Emily L C Tan
Hwee Cheng Tan
Lawrence W Stanton
P2860
P304
P356
10.3201/EID1004.030458
P577
2004-04-01T00:00:00Z